Objective To study the role of sirtuin 1 (SIRT1) in Fas ligand (FasL) expression regulation during vascular lesion formation and to elucidate the potential mechanisms.Methods SIRT1 and FasL protein levels were detected by Western blotting in either mouse arteries extract or the whole rat aortic vascular smooth muscle cell (VSMC) lysate.Smooth muscle cell (SMC)-specific human SIRT1 transgenic (Tg) C57BL/6 mice and their littermate wild-type (WT) controls underwent complete carotid artery ligation (ligation groups) or the ligation-excluded operation (sham groups).The carotid arteries were collected 1 day after operation.Reverse transcription-polymerase chain reaction was performed to detect the mRNA levels of SIRT1 and FasL.Luciferase reporter assays were performed to detect the effect of WT-SIRT1,a dominant-negative form of SIRT1 (SIRT1H363Y),and GATA-6 on the promoter activity of FasL.Flow cytometry assay was applied to measure the hypodiploid DNA content of VSMC so as to monitor cellular apoptosis.Results SIRT1 was expressed in both rat aortic VSMCs and mouse arteries.Forced SIRT1 expression increased FasL expression both in injured mouse carotid arteries 1 day after ligation (P<0.001) and VSMCs treated with serum (P<0.05 at the transcriptional level,P<0.001 at the protein level).No notable apoptosis was observed.Furthermore,transcription factor GATA-6 increased the promoter activity of FasL (P<0.001).The induction of FasL promoter activity by GATA-6 was enhanced by WT-SIRT1 (P<0.001),while SIRT1H363Y significantly relieved the enhancing effect of WT-SIRT1 on GATA-6 (P<0.001).Conclusions Overexpression of SIRT1 up-regulates FasL expression in both flow-restricted mouse carotid arteries and serum-stimulated VSMCs.The transcription factor GATA-6 participates in the transcriptional regulation of FasL expression by SIRT1. Objective To study the role of sirtuin 1 (SIRT1) in Fas ligand (FasL) expression regulation during vascular lesion formation and to elucidate the potential mechanisms. Methods SIRT1 and FasL protein levels were detected by Western blotting in either mouse arteries extract or the whole rat aortic vascular smooth muscle cell (VSMC) lysate. SMooth muscle cell (SMC) -specific human SIRT1 transgenic (Tg) C57BL / 6 mice and their littermate wild-type (WT) controls underwent complete carotid artery ligation (ligation groups) or the ligation The carotid arteries were collected 1 day after operation. Reverse transcription-polymerase chain reaction was performed to detect the mRNA levels of SIRT1 and FasL. Luciferase reporter assays were performed to detect the effect of WT-SIRT1, a dominant-negative form of SIRT1 (SIRT1H363Y), and GATA-6 on the promoter activity of FasL. Flow cytometry assay was applied to measure the hypodiploid DNA content of VSMC so as to monitor cellu lar apoptosis. Results SIRT1 was expressed in both rat aortic VSMCs and mouse arteries. Forced SIRT1 expression increased FasL expression both in injured mouse carotid arteries 1 day after ligation (P <0.001) and VSMCs treated with serum (P <0.05 at the transcriptional level , P <0.001 at the protein level. No notable apoptosis was observed. Fermentmore, transcription factor GATA-6 increased the promoter activity of FasL (P <0.001). The induction of FasL promoter activity by GATA-6 was enhanced by WT- SIRT1 (P <0.001) while SIRT1H363Y significantly relieved the enhancing effect of WT-SIRT1 on GATA-6 (P <0.001). Conclusions Overexpression of SIRT1 up-regulates FasL expression in both flow-restricted mouse carotid arteries and serum- stimulated VSMCs The transcription factor GATA-6 participates in the transcriptional regulation of FasL expression by SIRT1.